Showing results (31-40 of 44) with videos related to
Sort By:
Pageof 5
The European Respiratory Journal|January 15, 2021
Risk factors associated with the development of interstitial lung abnormalitiesIvette Buendía-Roldán, Rosario Fernandez, Mayra Mejía, et al.Clinical Rheumatology|April 20, 2024
Association between anti-PL7 antibodies and increased fibrotic component in patients with antisynthetase syndrome and interstitial lung disease: a cross-sectional studyDaphne Rivero-Gallegos, Mayra Mejía, Héctor I Rocha-González, et al.Pharmaceuticals (Basel, Switzerland)|August 28, 2021
Angiotensin-Converting Enzyme 2 (ACE2) in the Context of Respiratory Diseases and Its Importance in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) InfectionEnrique Ambrocio-Ortiz, Gloria Pérez-Rubio, Alma D Del Ángel-Pablo, et al.Cells|September 28, 2023
Molecular Factors in PAD2 (PADI2) and PAD4 (PADI4) Are Associated with Interstitial Lung Disease Susceptibility in Rheumatoid Arthritis PatientsKarol J Nava-Quiroz, Jorge Rojas-Serrano, Gloria Pérez-Rubio, et al.Journal of Immunology Research|June 20, 2015
Anti-Cyclic Citrullinated Peptide Antibodies and Severity of Interstitial Lung Disease in Women with Rheumatoid ArthritisAlberto Daniel Rocha-Muñoz, Manuel Ponce-Guarneros, Jorge Ivan Gamez-Nava, et al.Current Issues in Molecular Biology|July 27, 2022
COVID-19 Survivor Patients Carrying the Rs35705950 Risk Allele in MUC5B Have Higher Plasma Levels of Mucin 5BSalvador García-Carmona, Ramcés Falfán-Valencia, Abigail Verónica-Aguilar, et al.Archivos De Bronconeumologia|October 11, 2014
Procollagen Type I and III Aminoterminal Propeptide Levels and Severity of Interstitial Lung Disease in Mexican Women With Progressive Systemic SclerosisLaura Gonzalez-Lopez, Alberto D Rocha-Muñoz, Eva M Olivas-Flores, et al.Frontiers in Immunology|August 15, 2022
IFNAR2 relevance in the clinical outcome of individuals with severe COVID-19Ingrid Fricke-Galindo, Alfonso Martínez-Morales, Leslie Chávez-Galán, et al.Reumatologia Clinica|June 10, 2026
Guide from the Colegio Mexicano de Reumatología for the Pharmacological Treatment of Systemic Sclerosis Part 1: Cutaneous Involvement, Interstitial Lung Disease, and Pulmonary Arterial HypertensionKarla Chacón-Abril, Margarita Portela-Hernández, Luis Daniel Fajardo-Hermosillo, et al.The Journal of Infectious Diseases|March 16, 2022
TNFRSF1B and TNF Variants Are Associated With Differences in Levels of Soluble Tumor Necrosis Factor Receptors in Patients With Severe COVID-19Ingrid Fricke-Galindo, Ivette Buendía-Roldán, Andy Ruiz, et al.Pageof 5